'TrumpRx' website to offer discounted drugs as part of landmark Big Pharma deal



President Donald Trump unveiled a new deal to drastically reform the pharmaceutical industry and reduce drug prices for consumers.

Trump announced that Pfizer would be heavily discounting some of its "most popular medications" and that all new medications introduced in the U.S. markets would be sold at the "reduced Most Favored Nation cost." Trump also revealed that these discounted drugs will be available for purchase on a federally operated "TrumpRx" direct-to-consumer website.

'The big winner of this deal clearly will be the American patient.'

"It's going to have a huge impact on bringing Medicaid costs down, like nothing else. ... Especially, low-income Americans will be helped so greatly," Trump said in the Oval Office Tuesday.

"This is a consequential moment for our country," press secretary Karoline Leavitt said in a post on X. "Drug prices WILL be lower for everyday Americans, thanks to the negotiating prowess and determination of President Donald J. Trump. Democrats have been wanting to do this for decades. The Trump Administration has delivered."

RELATED: Health organizations attacking Trump's Tylenol-autism claims are cozied up with Big Pharma

pic.twitter.com/WGVNZLGsZS
— Rapid Response 47 (@RapidResponse47) September 30, 2025

Trump initially issued an executive order in May that directed drug companies to offer the "most-favored-nation" price for American patients. If they failed to do so, the Department of Health and Human Services would make a rule to implement the policy, and the Food and Drug Administration would revoke approvals for drugs that may be "unsafe, ineffective, or improperly marketed."

Trump also wrote to over a dozen major pharmaceutical CEOs in July demanding that the manufacturers voluntarily extend the "most-favored-nation" pricing to all medicines provided to Medicaid recipients. Trump gave these companies until Monday to formally respond.

"If you refuse to step up, we will deploy every tool in our arsenal to protect American families from continued abusive drug pricing practices," Trump wrote.

So far, Eli Lilly pledged to raise prices in Europe in order to lower costs in the United States. Bristol-Myers Squibb similarly plans to charge the same list price for a new schizophrenia treatment in both the United States and United Kingdom.

RELATED: Who is bankrolling the anti-MAHA movement?

Photo by Win McNamee/Getty Images

"The big winner of this deal clearly will be the American patient. There's no doubt about it," Pfizer CEO Albert Bourla said during the press conference. "They are the ones that will see significant impact in their ability to buy medicines."

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

Health organizations attacking Trump's Tylenol-autism claims are cozied up with Big Pharma



Medical establishmentarians have come out of the woodwork to condemn the Trump administration's recent autism announcement. Although these health organizations dispute the administration's findings from a medical perspective, many of them omit their close ties to pharmaceutical companies.

President Donald Trump and Health Secretary Robert F. Kennedy Jr. sparked outrage among the medical establishment by formally naming acetaminophen, the active ingredient in Tylenol, as one of the alleged culprits behind the exponential increase of autism in American children.

'The Trump administration does not believe popping more pills is always the answer.'

Trump and Kennedy's announcement suggested that pregnant women who take acetaminophen could be at an increased risk of having children with neurological conditions like autism and ADHD. Kennedy also indicated that the U.S. Food and Drug Administration will notify physicians of the findings and that the Department of Health and Human Services will launch a nationwide campaign to inform parents of the potential risks.

"For this reason, they are strongly recommending that women limit Tylenol use during pregnancy unless medically necessary," Trump said during the Monday announcement.

RELATED: Who is bankrolling the anti-MAHA movement?

Photo by Andrew Harnik/Getty Images

"The Trump administration does not believe popping more pills is always the answer for better health," press secretary Karoline Leavitt said in a statement. "There is mounting evidence finding a connection between acetaminophen use during pregnancy and autism — and that’s why the administration is courageously issuing this new health guidance."

A slew of medical organizations quickly came out against the findings, saying they are "filled with dangerous claims" and "irresponsible." At the same time, some of these same organizations have cozied up to pharmaceutical companies.

RELATED: Libs gobble Tylenol, foreign officials complain after Trump highlights autism link

Daniel Acker/Bloomberg via Getty Images

The American Psychiatric Association cautioned against the White House announcement, saying it was "incorrect to imply that a handful of studies have established causation."

"A strong base of evidence shows that acetaminophen, when taken as directed, is safe for use during pregnancy," the APA said in a statement. "Any decisions around a course of treatment should be determined by a patient and their doctor."

One of the many notable "patrons" that supports the APA Foundation includes Johnson & Johnson, which owned the Tylenol brand for decades before Kenvue took ownership in 2023. Other patrons include Alkermes, which produces a drug that is being tested for efficacy in treating autism, and Sage Therapeutics, which also has a drug development program to treat conditions like autism.

Other groups like the American College of Obstetricians and Gynecologists as well as the American Academy of Pediatrics have issued similar statements criticizing the administration's autism announcement.

RELATED: Trump administration claims link between autism and Tylenol, greenlights remedy

Photo by Mario Tama/Getty Images

"Today’s White House event on autism was filled with dangerous claims and misleading information that sends a confusing message to parents and expecting parents and does a disservice to autistic individuals," the AAP said in a statement.

"Suggestions that acetaminophen use in pregnancy causes autism are not only highly concerning to clinicians but also irresponsible when considering the harmful and confusing message they send to pregnant patients, including those who may need to rely on this beneficial medicine during pregnancy," the ACOG said in a statement.

Although the ACOG does not appear to have directly received funding from pharmaceutical companies, several have been listed as "supporters" of the organization. Meanwhile, the AAP's "Presidential Circle," which is made up of corporations that have donated $50,000 or more, includes household pharmaceutical companies like Pfizer and Moderna. The "Patron" donors list, which includes donations between $25,000 and $49,000, also includes Eli Lily and Genentech as partners.

The APA, the AAP, and the ACOG did not immediately respond to a request for comment from Blaze News.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

America is now playing by Corkins’ rules — unless we stop it



Floyd Lee Corkins. That name should ring louder than it does.

In 2012, Corkins stormed into the Family Research Council’s Washington, D.C., offices armed and intent on mass murder. A security guard stopped him before he could carry out a massacre. He became the first person convicted of domestic terrorism in the District of Columbia.

Corkins came once. His successors will come again. ... The question is what we’re prepared to do about it.

Yet you probably don’t recall him right away. Why not? Probably because the propaganda leaflets against Chick-fil-A and Christians found in his car tied back to groups like the Southern Poverty Law Center — and the press played down the obvious connection. They helped bury what Corkins meant to announce in blood: that political rhetoric backed by violence was the new normal.

I’ve long warned that when legitimate authorities fail to punish evil, someone eventually decides to take matters into his own hands. Corkins is the left’s demonic version of that. His case teaches a simple lesson: If you’re going to call conservatives Hitler, sooner or later someone will start acting on the metaphor.

That same logic drove the 2017 shooting at a congressional baseball practice, where a Bernie Sanders supporter nearly assassinated a swath of House Republicans. Rhetoric became ammunition. Talking points became bullets.

Fast-forward to 2025. The demons are autographing their shell casings. They want everyone to know exactly who wants us dead. And the corporate left-wing press winks and nods along.

Enter Jimmy Kimmel, a late-night host with fewer viewers than Glenn Beck can pull in an impromptu X Spaces session.

Kimmel should have been irrelevant years ago. But his network kept him on the air. Why? Not because he draws ratings or ad revenue — he doesn’t. He survives because of affinity advertising: the corporate and philanthropic subsidy system that props up “the right people” no matter how much red ink their shows spill. Pfizer, Disney, the Soros family — they all bankroll the propaganda they want in circulation, audience or no.

As the Joker explained while burning an enormous pile of cash, “It’s not about the money. It’s about sending a message.”

That’s why Kimmel could stand on stage and smear conservatives, even after Charlie Kirk’s assassination, and still be untouchable. His words carry the same function as Corkins’ bullets: intimidation dressed up as entertainment.

RELATED: Violence gave Jimmy Kimmel his job back

Blaze Media Illustration

The danger isn’t just one unfunny comedian. It’s the ecosystem that shields him. Advertisers and networks subsidize the message, the media excuses it, and the extremists absorb it as permission. That’s how rhetoric becomes carnage.

We face two choices. We can enforce the law, punish violent actors and those who materially enable them, and protect the marketplace of ideas. Or we can accept the Corkins rules: a culture where calling people Hitler is step one and shooting them is step two.

The notion that we can run in place like Mike Pence, emasculating ourselves for the sake of “proper tone” or one last bow to decorum, is a funeral march. Some may find comfort in that tune, but I will not bind my children’s future to it.

Corkins came once. His successors will come again. Kimmel’s sponsors and allies want you to think this is inevitable. It isn’t. The question is what we’re prepared to do about it.

Naomi Wolf continues to expose COVID vaccine: 'A depopulating technology'



Naomi Wolf's 1991 best-seller “The Beauty Myth” made her the most prominent face of so-called "third-wave feminism" and a darling of the liberal elite. The young Yale graduate and Rhodes scholar served as an adviser to both President Bill Clinton and — during his 2000 presidential run — Vice President Al Gore.

But then the COVID pandemic hit. For voicing her concerns about vaccine mandates and draconian lockdowns, Wolf found herself deplatformed from Twitter, marginalized as a so-called conspiracy theorist, and rejected by the same powerful Democrats who had once made her a star.

'A 13% to 20% drop in live births around the world, especially in Western, highly vaccinated countries.'

From Ms. to MAHA

Wolf, in turn, has left the Democrats behind. Seeing current Health and Human Services Secretary Robert F. Kennedy Jr. join the Trump campaign last year convinced her to endorse "the MAGA-MAHA ticket," she tells me via video call.

"I think it's a great thing for the country for these two groups of voters to be in alignment," she continues.

"What we're seeing right now ... the combination is making the Democratic Party obsolete. And as a lifelong Democrat, I wouldn't have ... said that was a good thing, except that the Democratic Party has turned into such a toxic, marginalized, self-marginalizing stew of festering special interests.”

With last year's release of “The Pfizer Papers,” based on the research of over 3,000 health care volunteers, edited by Wolf and Amy Kelly, Wolf has cemented her reputation as a courageous and supremely eloquent opponent of government overreach and globalist encroachment on public policy and free speech.

Neither safe nor effective

Wolf says that research points to the inescapable fact that Pfizer knew its vaccine was neither safe nor effective but released it on the public regardless because of an agenda that went way beyond mere corporate greed.

Wolf has sat down for this interview to discuss that research, which she recently presented before before the European Union Parliament after an invitation from German MEP Christine Anderson.

I note that Canada, too, has finally begun to question the efficacy and safety of the vaccine with the release of “Post-Covid Canada: The Rise of Unexpected Deaths” from the Justice Center for Constitutional Freedoms.

'My heart breaks for Canada'

For Wolf, this is a long time coming. In her view, the situation to her north is even worse than in her home country, with former Canadian Prime Minister Justin Trudeau overseeing "a horrible overall collapse of civil liberties and the rule of law ... and even basic norms of decency around life itself."

"My heart breaks for Canada all the time," Wolf continues.

“You have no Second Amendment. You have no First Amendment. People are scared — you know, when I go to Canada, people are really scared of what's going to happen to them if they are identified as critical of the government. You know, the poor truckers got de-banked and had to fight that fight back in 2022.”

Wolf describes Canada's major media as being “owned by your government," noting that “there’s been almost no coverage of 'The Pfizer Papers' in Canada."

I mention that Freedom Convoy trucker and protester Chris Barber could not only receive an eight-year sentence for “mischief" (the label the Crown has slapped on his peaceful protest), but could actually have his truck — the now iconic “Big Red” — expropriated by the Ontario provincial government and destroyed. Wolf is aghast.

RELATED: Sudden child deaths after COVID shots? Trump FDA director promises answers.

Photo by Anna Moneymaker/Getty Images

A feature, not a bug

For her part, Wolf has not faced any legal pushback from Pfizer, despite repeatedly calling out the pharmaceutical giant for its alleged culpability in vaccine injuries and deaths.

Nor is Wolf afraid to employ a comparison even her allies may find inflammatory, likening Pfizer's "Pregnancy and Lactation" report to "Nazi science" for the cavalier way it acknowledges the human toll of the vaccines.

“I'm not equating it with Nazi atrocities as a whole, in terms of scale,” Wolf says of the eight-page report Pfizer delivered to President Biden and then-CDC Director Rochelle Walensky.

"But it's a very terrifying document, because it showcases all the deaths and injuries to women and babies that Pfizer knew their injection had brought about, and ... it seems to be communicating the damage to women's reproduction is not a bug, but a feature of the injection, like, ‘Look how effective it is.’ For instance, they've got two babies who died in utero, and Pfizer concludes that it's due to maternal exposure to the vaccine.”

Drop in live births

Wolf notes that this information did not stop Walensky from urging the vaccine on pregnant women or women intending to get pregnant in August of that year.

"So that sequence of events in itself really raises questions, because she knew this would kill babies," says Wolf, raising the specter of infamous Nazi medical experimenter Dr. Josef Mengele.

"I don't make this comparison lightly," says Wolf, who is Jewish and notes that her grandparents lost a total of eight siblings to the Holocaust. "[But the report is] very Nazi medicine in its methodology, because there are charts. And one of the characteristics of Nazi medicine is [being] meticulous about horrific crimes and suffering.”

“So there are charts in this pregnancy and lactation report that show tens of thousands of women injured menstrually; 15,000 women bleeding every day, 10,000 women bleeding twice a month ... 7,500 women with no periods at all, meaning [that they're] totally infertile."

"A 13% to 20% drop in live births around the world, especially in Western, highly vaccinated countries," Wolf says, noting that "that's the takeaway in Canada as well."

Sinister finding

So was this all about the profit margin?

“As a journalist, I try never to go beyond the evidence. … I went into the project thinking, ‘Oh, I'm going to find out that they were just greedy, or they just cut corners.’ That's not what we found at all,” Wolf says.

The truth, according to her, is far more sinister. “There are a number of data points that show that Pfizer intended to create a depopulating technology and that all the people up and down the chain of command — CDC, FDA, the president — knew," Wolf says.

"That's why I think the pregnancy and lactation report is so important, and that that was the main function — is to depopulate the West and also to create a massive scale of injury and and death, in addition to sterilization and pregnancy loss.”

Pfizer sets sights on new obesity drug market in multibillion-dollar acquisition



A little more than five months after Pfizer discontinued development of its weight-loss drug known as danuglipron, the drugmaker announced its plan on Monday to acquire a biopharmaceutical company for close to $5 billion.

Pfizer published a press release on Monday confirming the unanimous agreement to acquire Metsera, a "clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and cardiometabolic diseases."

'Obesity is a large and growing space with over 200 health conditions associated with it.'

According to the terms of the agreement, Pfizer will acquire all outstanding shares of Metsera common stock for $47.50 per share in cash at closing, representing an enterprise value of approximately $4.9 billion.

While Pfizer reportedly does not have any obesity drugs on the market, Metsera has "a portfolio of differentiated oral and injectable incretin, non-incretin, and combination therapy candidates with potential best-in-class efficacy and safety profiles," per the press release.

RELATED: FDA slaps damning warnings on COVID-19 vaccines; highlights Biden administration's safety-risk gloss

Photo Illustration by Thomas Fuller/SOPA Images/LightRocket via Getty Images

The portfolio includes drug trials at different stages of development, including "two oral GLP-1 RA candidates expected to begin clinical trials imminently."

“Obesity is a large and growing space with over 200 health conditions associated with it. The proposed acquisition of Metsera aligns with our focus on directing our investments to the most impactful opportunities and propels Pfizer into this key therapeutic area,” Pfizer chairman and CEO Albert Bourla said in the press statement.

“Since our founding in 2022, Metsera has worked tirelessly to reduce the physical, emotional, and economic burdens of obesity with a portfolio of next-generation nutrient-stimulated hormone therapeutic candidates. Our team has invented and developed multiple injectable and oral candidate medicines and a category-leading peptide engineering platform, which together promise class-leading performance in a major sector of population health,” said Whit Bernard, co-founder and CEO of Metsera.

In the press release, neither company mentioned or acknowledged well-known weight-loss techniques like calorie-deficit dieting and consistent exercise as part of a healthy regimen. Blaze News did not receive a response from Pfizer or Metsera when asked to clarify their stance on diet and exercise.

Weight-loss drug production, as it turns out, is a very lucrative business to be in. A Nasdaq article from the beginning of 2024 laid out the pathway for Danish company Novo Nordisk, the producer of flagship obesity drugs like Wegovy and Ozempic, to potentially reach a valuation of $1 trillion by 2030. It's possible that the explosion of interest in and availability of weight-loss drugs has pushed tried-and-true methods to the side.

"With a number like that, of course this drug is the answer! It has to be the answer," Health and Human Services Secretary Robert Kennedy said last year on X, referring to the $1 trillion speculation about Novo Nordisk's obesity drugs. "With a number like that, of course we don't talk about root causes; and about the need for better food and saner farming."

Pfizer and Metsera expect the transaction to be finalized by the end of the fourth quarter of 2025.

Blaze News contacted the Health and Human Services press office about the pending acquisition but did not receive a response.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

All The Companies That Advertised On The MSNBC Segment Blaming Charlie Kirk For His Own Death

Numerous companies, including Pfizer, The Economist, and P&G brands, ran advertisements on Katy Tur Reports on MSNBC Wednesday, during which Tur and one of her guests smeared Charlie Kirk following the news that he had been shot. These and other companies did not commit to pulling their advertisements from MSNBC in response to a Federalist […]

CDC insider has message for Trump on vaccines



Over the weekend, President Donald Trump broke free of his usual pro-COVID vaccine sentiment and appeared to openly question pharmaceutical companies in a post on Truth Social.

“It is very important that the Drug Companies justify the success of their various Covid Drugs. Many people think they are a miracle that saved millions of lives. Others disagree! With CDC being ripped apart over this question, I want the answer, and I want it NOW,” Trump began in his post.

“I have been shown information from Pfizer, and others, that is extraordinary, but they never seem to show those results to the public. Why not??? They go off to the next ‘hunt’ and let everyone rip themselves apart, including Bobby Kennedy Jr. and CDC, trying to figure out the success or failure of the Drug Companies Covid work,” he continued.


“I want them to show them NOW to the CDC and the public, and clear up this MESS, one way or the other!!! I hope OPERATION WARP SPEED was as ‘BRILLIANT’ as many say it was. If not, we all want to know about it, and why???” he added.

Centers for Disease Control and Prevention insider Dr. Robert Malone, who’s been on the front lines of the vaccine fight ever since the beginning of the COVID-19 pandemic, has his own thoughts on the matter.

“In public health, I don’t think that we’ve ever had a period of time, a window of time, in which the underlying culture and a lot of the established conceptions of particularly the vaccine sector being challenged so actively,” Malone tells BlazeTV host Liz Wheeler in response to Trump's post on “The Liz Wheeler Show.”

But the COVID vaccine isn’t even close to the only one that Trump should be questioning.

“There is a culture, and it really has earned the name of the term, being a cabal. There is a culture, an obsessive culture of vaccination. And let’s be real here. Vaccines are just another pharmaceutical. That’s all they are. They are not a magic bullet that cures all infectious disease,” Malone tells Wheeler.

“Influenza vaccination is something like less, well less than 50% effective. Sometimes it’s almost down in the single digit,” he continues.

However, the “experts” refuse to acknowledge this.

“They act as if they are untouchable, that their determinations are God’s truth and shall not be questioned,” Malone tells Wheeler, adding, “This is scientism.”

Want more from Liz Wheeler?

To enjoy more of Liz’s based commentary, subscribe to BlazeTV — the largest multi-platform network of voices who love America, defend the Constitution, and live the American dream.

How Top Companies Bankrolled a Qatari Influence Op

In 2021, Pfizer and Amazon earned perfect scores on the Corporate Equality Index, a rating of how well companies treat their LGBT employees. Overseen by the Human Rights Campaign, which seeks to ensure that "LGBTQ+ people" are treated "as full and equal citizens … around the world," the index grades companies on their "workplace inclusion" and "support for LGTBQ equality under the law."

The post How Top Companies Bankrolled a Qatari Influence Op appeared first on .

FDA slaps damning warnings on COVID-19 vaccines; highlights Biden administration's safety-risk gloss



Federal health authorities rebuked Florida Surgeon General Dr. Joseph Ladapo for suggesting in 2022 that the benefit of COVID-19 vaccination among healthy young men was outweighed by the risk of heart conditions, myocarditis in particular.

Ladapo issued guidance that stated, "Based on currently available data, patients should be informed of the possible cardiac complications that can arise after receiving a mRNA COVID-19 vaccine."

“Our goal is not to get into like a fight or a tiff, because public health isn’t served well by this,” said Dr. Peter Marks, then-director of the U.S. Food and Drug Administration's Center for Biologics Evaluation and Research. "Our goal is to help get to … an acceptance that there are overall benefits of these vaccines, despite the fact that yes, it is true that there could be some side effects."

'Most of these patients had received a two-dose primary series of an mRNA COVID-19 vaccine prior to their diagnosis.'

Marks' former agency has since acknowledged that there is a greater risk of post-vaccination myocarditis than the so-called experts were first willing to publicly admit.

Months after telling both vaccine manufacturers to include new safety information regarding their respective drugs in the stated interest of "radical transparency," the FDA indicated on June 25 that it required Pfizer and Moderna to note the estimated unadjusted incidence of heart conditions following administration of the 2023-2024 formula of the Comirnaty and Spikevax vaccines, as well as the longitudinal results of a 2024 study concerning cardiac manifestations and outcomes of vaccine-associated myocarditis in American youths.

The FDA also required Pfizer and Moderna to describe the new safety information in the adverse reactions section of their vaccine information inserts.

RELATED: How Big Pharma left its mark on woke CDC vax advisory panel — and what RFK Jr. did about it

Photo illustration by Joe Raedle/Getty Images

For years, the fact sheets for the mRNA COVID-19 vaccines noted that reports of adverse events demonstrated increased risks of myocarditis and pericarditis, particularly following the second dose, and that the "observed risk is highest in males 12 through 17 years of age."

Now, the package inserts state that "the observed risk has been highest in males 12 years through 24 years of age" and:

Based on analyses of commercial health insurance claims data from inpatient and outpatient settings, the estimated unadjusted incidence of myocarditis and/or pericarditis during the period 1 through 7 days following administration of the 2023-2024 Formula of mRNA COVID-19 vaccines was approximately 8 cases per million doses in individuals 6 months through 64 years of age and approximately 27 cases per million doses in males 12 through 24 years of age.

The package inserts for both drugs also now state:

Follow-up information on cardiovascular outcomes in hospitalized patients who had been diagnosed with COVID-19 vaccine-associated myocarditis is available from a longitudinal retrospective observational study. Most of these patients had received a two-dose primary series of an mRNA COVID-19 vaccine prior to their diagnosis. In this study, at a median follow-up of approximately 5 months post-vaccination, persistence of abnormal cardiac magnetic resonance imaging (CMR) findings that are a marker for myocardial injury was common. The clinical and prognostic significance of these CMR findings is not known. Information is not yet available about potential long-term sequelae of myocarditis or pericarditis following administration of mRNA COVID-19 vaccines.

When discussing the updates, Dr. Vinay Prasad, director of the FDA's Center for Biologics Evaluation and Research, provided a refresher about the effort by the previous administration to downplay the risk of myocarditis.

Prasad, referring to congressional testimony given by Sen. Ron Johnson (R-Wis.) in May, noted that Centers for Disease Control and Prevention and the FDA officials were aware in early 2021 of a safety signal for the heart condition on the basis of Pentagon and Israeli data.

'The FDA's new Covid-19 philosophy represents a balance of regulatory flexibility and a commitment to gold-standard science.'

A day after health officials at the agencies acknowledged a safety signal, and after the CDC discussed whether to issue a Health Alert Network message on myocarditis, the Biden White House distributed talking points to top U.S. health officials de-emphasizing the risk.

On May 26, 2021, then-acting FDA Commissioner Janet Woodcock told then-CDC Director Rochelle Walensky that the "FDA does not concur with the issuance of the myocarditis HAN as written."

That day, both agencies reportedly decided to "nix the HAN" alert.

"The risk of myocarditis and pericarditis appears to be very low given the number of vaccine doses that have been administered," Woodcock stated the following month. "The benefits of COVID-19 vaccination continue to outweigh the risks, given the risk of COVID-19 diseases and related, potentially severe, complications."

The nixed alert could have made a difference.

After all, Prasad noted that "in August of 2021, in an FDA regulatory action, we document that based on the health insurance claims Optum dataset, the rate of post-vaccination myocarditis from the Pfizer-BioNTech vaccine was approaching 200 cases per million or approximately 1 in 5,000" among 16- and 17-year-old males.

RELATED: Democrats who locked down America during COVID now cry dictator over Trump's deportations

— (@)

FDA Commissioner Martin Makary and Prasad noted in a May article in the New England Journal of Medicine that "the FDA’s new Covid-19 philosophy represents a balance of regulatory flexibility and a commitment to gold-standard science. The FDA will approve vaccines for high-risk persons and, at the same time, demand robust, gold-standard data on persons at low risk."

Blaze News reached out to the FDA but did not immediately receive a response.

Like Blaze News? Bypass the censors, sign up for our newsletters, and get stories like this direct to your inbox. Sign up here!

House Judiciary Targets Ex-Pfizer Executive With Subpoena

'Pfizer’s representatives are or will be in communication'